Tonix Pharmaceuticals Holding Corp. (TNXP)
14.10
-0.24
(-1.67%)
USD |
NASDAQ |
Apr 16, 16:00
14.09
-0.01
(-0.07%)
After-Hours: 17:07
Tonix Pharmaceuticals Research and Development Expense (Annual) : 44.49M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Phio Pharmaceuticals Corp. | 4.618M |
| Jaguar Health, Inc. | 24.97M |
| MetaVia, Inc. | 6.802M |
| Seastar Medical Holding Corp. | 7.518M |
| Jupiter Neurosciences, Inc. | 2.087M |